| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 74.642 | 112.335 | 61.498 | 18.878 | 74.822 | 865.160 |
| Total Income - EUR | - | - | - | - | 75.879 | 143.837 | 73.262 | 39.727 | 135.692 | 865.727 |
| Total Expenses - EUR | - | - | - | - | 57.729 | 127.943 | 86.616 | 61.261 | 128.980 | 844.028 |
| Gross Profit/Loss - EUR | - | - | - | - | 18.149 | 15.894 | -13.354 | -21.534 | 6.712 | 21.698 |
| Net Profit/Loss - EUR | - | - | - | - | 17.403 | 14.757 | -13.991 | -21.931 | 5.376 | 17.717 |
| Employees | - | - | - | - | 1 | 1 | 2 | 2 | 1 | 1 |
Check the financial reports for the company - Bio-Leg Brezoaele S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 55.143 | 50.258 | 58.984 | 56.354 | 16.641 | 16.008 |
| Current Assets | - | - | - | - | 24.781 | 78.539 | 39.603 | 39.148 | 6.176 | 103.331 |
| Inventories | - | - | - | - | 17.462 | 39.959 | 26.617 | 34.791 | 3.278 | 4.976 |
| Receivables | - | - | - | - | 5.421 | 34.457 | 8.567 | 2.946 | 2.615 | 82.498 |
| Cash | - | - | - | - | 1.899 | 4.123 | 4.419 | 1.411 | 283 | 15.856 |
| Shareholders Funds | - | - | - | - | 17.445 | 31.871 | 17.137 | -5.385 | 7 | 17.724 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 62.480 | 96.926 | 81.450 | 100.888 | 22.810 | 101.615 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "113 - 113" | |||||||||
| CAEN Financial Year |
4631
|
|||||||||
Comments - Bio-Leg Brezoaele S.r.l.